The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

WHO’s new guidance supports Ozempic-class GLP-1 drugs for obesity treatment, but only alongside behavioural therapy and ...

Here are 5 things health experts say to expect after you stop taking GLP-1 drugs, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).

Adventist Health White Memorial says it is taking steps to reaffirm its commitment to patient privacy in the face of ICE ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Constipation is a common but manageable side effect of Ozempic, a medication for diabetes and weight loss. It often occurs in ...

Denmark’s biggest exports include Ozempic, Carlsberg and Lego. But now, European leaders think it has something more valuable to sell: an immigration system tough and effective enough to neuter the ...

Some people taking popular new diabetes and weight-loss drugs including Ozempic, Wegovy, Zepbound and Mounjaro have reported reduced cravings for substances besides food. The medications seem to ...

Some people may notice weight gain while using Ozempic or after stopping the drug. Reasons for weight gain while using Ozempic may include changes in appetite and reduced physical activity due to side ...

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...